Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging

Similar documents
Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging

7 th Edition Staging. AJCC 7 th Edition Staging. Disease Site Webinar. Colorectum. Overview. This webinar is sponsored by

AJCC 7 th Edition Staging Disease Site Webinar Colorectum

Seventh Edition Staging 2017 Breast

Seventh Edition Staging 2017 Colorectum. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Seventh Edition Staging 2017 Melanoma. Overview. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Lesson 8 Classifications

Introduction & Descriptors

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by

Registrar s Guide to Chapter 1, AJCC Seventh Edition. Overview. Learning Objectives. Describe intent and purpose of AJCC staging

Major Rule Changes. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

AJCC 8 th Edition Staging. Introduction & Descriptors. Learning Objectives. This webinar is sponsored by

Interactive Discussion of Part I CS Coding Instructions: Working the Cases

AJCC 8 th Edition Staging. Minor Rule Changes. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention.

Minor Rule Changes. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

2018 IMPLEMENTATION UPDATE: WHAT S NEW IN STAGING FOR 2018?

AJCC-NCRA Education Needs Assessment Results

AJCC 8 th Edition Staging. Head & Neck Staging. Learning Objectives. This webinar is sponsored by. the Centers for Disease Control and Prevention.

AJCC Cancer Staging 8 th Edition

Head & Neck Staging. Donna M. Gress, RHIT, CTR Technical Editor, AJCC Cancer Staging Manual First Author, Chapter 1: Principles of Cancer Staging

5/8/2014. AJCC Stage Introduction and General Rules. Acknowledgements* Introduction. Melissa Pearson, CTR North Carolina Central Cancer Registry

AJCC 7 th FAQ-1. General Rules for Staging. Question:

The Voyage to Direct Coding of AJCC TNM & Stage... Jayne Holubowsky, CTR DelMarVa-DC Educational Meeting Annapolis, MD October 8, 2015.

AJCC Cancer Staging 8 th Edition. Prostate Chapter 58. Executive Committee, AJCC. Professor and Director, Duke Prostate Center

Staging for Residents, Nurses, and Multidisciplinary Health Care Team

Q: How do you clinically code the N if the nodes are stated to be positive on mammogram/us or other imaging? No biopsy of nodes was done.

Kidney Q&A 5/5/16 Q1: Can we please get that clarification sent with the presentation and Q&A? Also a start date for that clarification

Data Harmonization Efforts Across the Cancer Staging System. Donna M. Gress, RHIT, CTR AJCC Technical Specialist

A CENTRAL REGISTRY RELIABILITY STUDY

AJCC TNM STAGING UPDATES ARE YOU READY FOR TNM?

MCR MINI UPDATE DECEMBER 2017

Completing the Puzzle AJCC TNM Staging Breast. Nicole Catlett, CTR 2017 Kentucky Cancer Registry Fall Conference, September 21 & 22, 2017

CS Evaluation Fields. Outline of Presentation. Purpose of Evaluation Field. CSv2 Title of Presentation Jan 2011 Lecture Version: 1.

NPCR s TNM Stage Calculator

Outline. How to Use the AJCC Cancer Staging Manual, 7 th ed. 7/9/2015 FCDS ANNUAL CONFERENCE ST PETERSBURG, FLORIDA JULY 30, 2015.

Shore Medical Center Site-Specific Study: Colorectal Cancer 2013

4/10/2018. SEER EOD and Summary Stage. Overview KCR 2018 SPRING TRAINING. What is SEER EOD? Ambiguous Terminology General Guidelines

47. Melanoma of the Skin

In The Abstract. KCR Fall Workshop Goes Regional. Calendar of Events

SEER Summary Stage Still Here!

General Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators

Question: If in a particular case, there is doubt about the correct T, N or M category, what do you do?

Version 2 Overview and Update CSv0202 to CSv0203

Commission on Cancer Updates

Making the Most of Your Cancer Registry

CANCER REPORTING IN CALIFORNIA: ABSTRACTING AND CODING PROCEDURES California Cancer Reporting System Standards, Volume I

Lung /4/18. Please submit all questions concerning the webinar content through the Q&A panel.

Thursday, August 16, :30 AM - 4:30 PM and Friday, August 17, :30 AM 12:00 PM Crowne Plaza 830 Phillips Lane Louisville, KY 40209

6. Cervical Lymph Nodes and Unknown Primary Tumors of the Head and Neck

You Want ME to Stage that Case???

Case Scenario 1 Worksheet. Primary Site C44.4 Morphology 8743/3 Laterality 0 Stage/ Prognostic Factors

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

Thyroid and Adrenal Gland

Exercise 15: CSv2 Data Item Coding Instructions ANSWERS

Interactive Staging Bee

ACOS Inquiry and Response Selected Inquires CS Tumor Size/Extension Evaluation, CS Lymph Nodes Evaluation, CS Metastasis at Diagnosis Evaluation *

Education & Training Plan

Descriptor Definition Author s notes TNM descriptors Required only if applicable; select all that apply multiple foci of invasive carcinoma

A Practicum Approach to CS: GU Prostate, Testis, Bladder, Kidney, Renal Pelvis. Jennifer Ruhl, RHIT, CCS, CTR Janet Stengel, RHIA, CTR

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

14. Mucosal Melanoma of the Head and Neck

This form may provide more data elements than required for collection by standard setters such as NCI SEER, CDC NPCR, and CoC NCDB.

EVERYTHING YOU WANTED TO KNOW ABOUT. Robin Billet, MA, CTR, Head & Neck CTAP Member May 9, 2013

Stage: The Language of Cancer

2007 New Data Items. Slide 1. In this presentation we will discuss five new data items that were introduced with the 2007 MPH Coding Rules.

11/21/13 CEA: 1.7 WNL

STAGE CATEGORY DEFINITIONS

SEER 2014 TNM Training Needs Assessment Study

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

2018 Grade PEGGY ADAMO, RHIT, CTR OCTOBER 11, 2018

10. HPV-Mediated (p16+) Oropharyngeal Cancer

3/23/2017. Disclaimer. Common Changes in TNM Staging. Overview. Overview. Understanding Terminology. Overview

Education & Training Plan FCDS Webcast Series Anatomic Staging Focus

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

Kyle L. Ziegler, CTR. California Cancer Registry U.C. Davis Health System

Coding Pitfalls 9/1/2011. Coding Pitfalls Questions. Fabulous Prizes!!! September 1, NAACCR Webinar Series 1

Newton Wellesley Hospital 2013

NAACCR Grade 2018 Q & A

Collaborative Staging

Setting the stage for change: upgrading the physician cancer case reporting application in New York

AJCC TNM 6 th Edition Staging Input Data Dictionary

Q&A for Collecting Cancer Data: Unusual Sites and Histologies Thursday, October 1, 2015

2016 CANCER PROGRAM REPORT. Bay Medical Sacred Heart Health System 615 North Bonita Avenue Panama City, FL

Coding Pitfalls 9/11/14

Purposes and Principles of Cancer Staging

Coding Pitfalls 9/3/15

Colon, Rectum, and Appendix. Presentation Outline. Overview Tumor Characteristics

Colon, Rectum, and Appendix

NUMERATOR: Reports that include the pt category, the pn category and the histologic grade

Change Log V1.3- v1.4

COLLECTING CANCER DATA: STOMACH AND ESOPHAGUS

46. Merkel Cell Carcinoma

NAACR Treatment Webinar Quiz 1

1/25/13 Right partial nephrectomy followed by completion right radical nephrectomy.

Esophagus, Esophagus GE Junction, Stomach

Case Scenario year-old white male presented to personal physician with dyspepsia with reflux.

Testicular Malignancies /8/15

NCDB Vendor Webinar: NCDB Call for Data January 2018 and Upcoming RQRS Revisions

FORDS to STORE: The Evolution of Cancer Registry Coding Frederick L. Greene, MD FACS Medical Director, Cancer Data Services Levine Cancer Institute

Transcription:

Explaining Blanks and X, Ambiguous Terminology and Support for AJCC Staging Donna M. Gress, RHIT, CTR Validating science. Improving patient care. This presentation was supported by the Cooperative Agreement Number DP13-1310 from The Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of The Centers for Disease Control and Prevention.

Overview Provide guidance to cancer registrars on key topics Blank vs. X in registry data fields Ambiguous terminology Stage classification to use based on treatment provided Guidelines from other sources Information and questions on AJCC staging 2

Learning Objectives Recognize difference in definitions of blank and X Demonstrate correct usage of blank and X Employ critical thinking to terminology used Analyze physician terminology intent by multiple methods Determine stage classifications to apply by treatment choice Utilize appropriate guidelines Identify resources for AJCC staging 3

Registry Data Fields Blank vs. X

Completing Registry Data Fields Registry data fields seen on software screen CLINICAL T N M Stage Group PATHOLOGIC T N M Stage Group Use appropriate c or p data fields Based on what is needed to assign stage correctly Follows AJCC staging rules Do NOT use just elements in that one line Match stage assigned by physician According to AJCC rules 5

Blank vs. X AJCC defines X for T and N categories Cannot be assessed Cannot use X for other situations No surgical resection is NOT ptx pnx pm blank Stage 99 Blank should be used when No information is available in chart Cannot be assigned a valid AJCC value Patient not eligible for pathologic stage 6

Registry Data Fields - Examples Patient had bowel obstruction and went directly to surgery where colon cancer was found Physician assigned pathologic stage pt4a pn2a cm0 Stage IIIC ct blank cn blank cm0 Stage group blank or 99 pt4a pn2a pm blank Stage group 3C Cannot assign clinical stage, cancer not known prior to definitive treatment AJCC is stage group blank, but CoC requires non-blank value for clinical stage pm is blank because appropriate M is cm0 7

Registry Data Fields - Examples Patient had CT chest with LLL tumor and mediastinal nodes, mediastinotomy removed 4 nodes confirming N3 disease, concurrent chemoradiation will be given Physician assigned clinical stage T2a N3 M0 Stage IIIB (implied c, same as ct2a cn3 cm0) ct2a cn3 cm0 Stage group 3B pt blank pn blank pm blank Stage group blank Biopsy of nodes is part of staging workup, cn Cannot assign pathologic stage, no resection of primary Not stage 99, implies criteria met but information unknown 8

Registry Data Fields - Examples Clinical stage of insitu cancer of breast, with total mastectomy and no nodal resection ct blank cn0 cm0 Stage group 0 ptis pn blank pm blank Stage group 0 Can assign clinical and pathologic stage Rules state in situ assigned ptis cn0 cm0 for clinical and pathologic ptis for clinical stage means ct is left blank Rules state both clinical and pathologic stage 0 Rule put in place because nodes are usually not resected for in situ cancers Meets breast criteria for pathologic classification 9

Registry Data Fields - Examples Clinical stage of insitu cancer of bladder with TURB and no cystectomy ct blank cn0 cm0 Stage group 0 ptis pn blank pm blank Stage group blank Cannot assign pathologic stage Bladder criteria of cystectomy has not been met Common to not find invasive tumor on TURB Do not use stage group 99, pathologic stage criteria not met 99 implies criteria met but information unknown Rules state that in situ assigned ptis cn0 cm0 10

Registry Data Fields - Examples Diagnostic workup includes biopsy of bone showing mets from breast ca, no breast resection ct1 cn1 cm blank Stage Group 4 ptblank pnblank pm1 Stage Group 4 pm1 for clinical stage, biopsy was during workup pm1 is both clinical and pathologic stage IV according to AJCC rules Case with pm1 may be grouped as clinical and pathologic stage IV regardless of c or p status of T and N 11

CoC FORDS Values Blank, X, 88, 99 T, N, and M data fields Values allowed by FORDS Further explanations from AJCC Blank indicates No information in medical record Do not know if any assessment was performed Criteria not met for this stage classification so each category (T,N,M) is blank X indicates not assessed T cannot be assessed N cannot be assessed Does not apply to M, if patient was examined it can be assigned Criteria met for this stage classification so each category is valid value or X 88 indicates not applicable, not defined by AJCC 12

CoC FORDS Values Blank, X, 88, 99 Stage group data fields Values allowed by FORDS Further explanations from AJCC Blank indicates No information in medical record or Criteria not met for pathologic staging CoC does not allow blank for clinical staging 99 indicates unknown, not defined by AJCC 99 indicates T or N are unknown, and stage cannot be assigned 99 indicates T, N, or M are not specific enough to assign stage Example: T2 assigned when T2a or T2b needed to assign stage CoC mandates non-blank for clinical stage group, use 99 Do not use 99 if pathologic staging criteria not met, use blank 88 indicates not applicable, not defined by AJCC 13

Key Points for Blank & X Does patient meet criteria for that stage classification? Yes patient meets classification criteria If physician could not assess T and/or N for the patient, and Definitive information for T and N not in chart Use TX and/or NX Yes patient meets classification criteria No information about diagnostic workup or resection pathology in chart Do not use X Implies physician did not assess or have info on patient s T and/or N Use blank Indicates registrar could not find information in chart 14

Key Points for Blank & X Does patient meet criteria for that stage classification? No patient does NOT meet classification criteria Do NOT use X Indicates patient eligible for staging Implies physician did not assess or have info on patient s T and/or N Must use blanks Indicates patient did not meet classification criteria 15

Key Points for Blank & X X can only be used according to AJCC definitions Must use blanks if AJCC criteria for X is not met Remember MX does NOT exist Assigning cm0 only requires patient to have had H&P Does not mean registrar must find H&P on chart If physician suspects mets It will be mentioned Treatment plan will be different 16

Ambiguous Terminology

Ambiguous Terminology AJCC does NOT Define ambiguous terminology Mandate how words should be interpreted How to interpret words for cancer involvement Review clinician s statements Treatment choices may indicate clinician s impression Review and analysis of entire case Physical exam Medical history of all other diseases Symptoms Imaging Lab tests Diagnostic procedures All other available information Judgment call based on all aspects of patient s care 18

Ambiguous Terminology Example Lung case CT chest reports mediastinal adenopathy Patient scheduled for LUL lobectomy Are the mediastinal nodes involved with cancer? Imaging analysis CXR are not sensitive and enlarged nodes may be involved CT, MRI, PET are very sensitive, could be infection, inflammation, immune system reaction, or cancer Treatment analysis NCCN guidelines indicate surgery is not the primary therapy for known involvement of mediastinal nodes (N2) Decision: mediastinal nodes are NOT involved 19

Ambiguous Terminology Example Duodenum case CT abd/pelvis reports duodenal tumor with extensive inflammation, exudate and adherent to other loops of small bowel Patient scheduled for resection of tumor in duodenum Does adherence mean other bowel involved with cancer? Imaging and treatment analysis Exudate is fluid leaking from blood vessels due to inflammation Inflammation causing adherence, not tumor, if extensive adherence they would not resect just local tumor and not do more treatment, either more surgery or chemotherapy Decision: other small bowel are NOT involved 20

Stage Classification Based on Treatment

Stage Classification Based on Treatment Surgical Treatment Clinical Pathologic Systemic and/or Radiation ONLY Clinical Neoadjuvant Therapy Clinical yclinical (after systemic/radiation but before surgery) ypathologic (after systemic/radiation AND surgery) 22 Can NEVER do pathologic after neoadjuvant therapy Registrars do not have data field to record yc

Guidelines from Other Sources

CS Rules NOT Used for AJCC CS rules do not apply to AJCC Underlying principles are similar Detailed rules are not the same 24

CS Rules NOT Used for AJCC CS rules do not apply to AJCC AJCC Clinical and pathologic based on Different points in time Specific criteria Not exactly same as CS eval codes 25

CS Rules NOT Used for AJCC Rootstock this is foundation or base of a plant Graft plant that you want to grow It would not grow or survive on its own This plant needs a strong foundation or base It is grafted onto a rootstock which provides strong foundation Example on next slide is Left - Jacaranda tree = AJCC Tree is all AJCC, rootstock and entire plant, no grafts Right - Royal Poinciana = Collaborative Stage Tree is EOD & Summary Stage grafted onto AJCC rootstock Trees are very different they are not the same 26

AJCC and CS Are Not The Same AJCC is the rootstock and entire tree CS is EOD & Summary Stage grafted onto the AJCC rootstock 27

Other Sources Not Used for AJCC Staging Guidelines from other sources cannot be used for assigning AJCC stage Other sources not used for assigning AJCC stage MPH CS FORDS (only use allowable codes, do not use ambiguous terms or any rules for assigning AJCC TNM) SEER Program Coding Manual Any manual that is not AJCC 7 th edition Cancer Staging Manual or Handbook AJCC 2 nd edition Cancer Staging Atlas Rules are valid only for publication to which they belong 28

Information and Questions on AJCC Staging

AJCC Web site https://cancerstaging.org Cancer Staging Education menu includes Articles 18 articles on AJCC staging in various medical journals Resources Staging Moments 15 case-based presentations in cancer conference format to promote accurate staging with answers and rationales Webinars 14 free webinars on staging rules and some disease sites Watch for education plans and content in the future 30

AJCC Cancer Staging Manual and Atlas 31 Order at http://cancerstaging.net

CAnswer Forum Submit questions to AJCC Forum Located within CAnswer Forum Provides information for all Allows tracking for educational purposes http://cancerbulletin.facs.org/forums/ 32

Summary

Summary Discriminate between blank and X usage Assign X according to AJCC rules Apply critical thinking when interpreting physician s words Do not use registry ambiguous terminology lists Take into account available information Recognize appropriate stage classifications for each case Treatment choices will identify eligible stage options Differentiate guidelines available for registrars Identify resources Information and guidance Obtain answers to questions 34

Thank you Donna M. Gress, RHIT, CTR AJCC Technical Specialist 633 N. Saint Clair, Chicago, IL 6011-3211 cancerstaging.org No materials in this presentation may be changed without the express written permission of the American Joint Committee on Cancer. Permission requests may be submitted at CancerStaging.net